Consumer comments open for CAR-T cell therapy funding for myeloma in Australia

Consumer comments open for CAR-T cell therapy funding for myeloma in Australia What is CAR-T cell therapy? CAR-T stands for ‘Chimeric Antigen Receptor T Cell’ and is a type of treatment known as an im...

PBAC meeting July 2020

At the upcoming Pharmaceutical Benefits Advisory Committee (PBAC) meeting in July, there will be two submissions made relating to drugs that are used to treat myeloma, namely daratumumab and carfilzom...

BLOOD

A team from Myeloma Australia had the opportunity to attend ‘Blood2018’ (formerly HAA) the largest haematology conference in Australia in Brisbane at the end of October. With our team of ten Myeloma S...

Sydney City2Surf Running Blog

Running blog “Let the training commence” “White rabbits” “pinch, punch first day of the month” also day one of my training for “Team Myeloma” City to Surf 2018! I have entered this event several times...

PBAC consumer comments open for denosumab

Myeloma Australia is committed to keeping the Australian myeloma community informed about any new treatment submissions to be considered by the Pharmaceutical Benefits Advisory Committee (PBAC). The P...

Fundraising update

There is much activity at this time in the fundraising space of Myeloma Australia. Our first major fundraising event for the year was our flagship Business of Winning Luncheon at the MCG. This was a g...

Social media & sharing icons powered by UltimatelySocial